In recent years, innovative therapies have sparked renewed hope for patients facing complex ocular conditions. Vasoactive Intestinal Peptide (VIP) is emerging as a groundbreaking...
Diabetic retinopathy is a leading cause of visual impairment globally, driven by chronic hyperglycemia that damages the retinal microvasculature over time. Traditional interventions—ranging from...